相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mitotic rate in melanoma should be recorded as the number of mitoses per mm2 (not per high power field): surgeons tell your pathologists!
Richard A. Scolyer et al.
AMERICAN JOURNAL OF SURGERY (2013)
BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma
Graham J. Mann et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Prognostic Importance of the Extent of Ulceration in Patients With Clinically Localized Cutaneous Melanoma
Florentien E. M. in't Hout et al.
ANNALS OF SURGERY (2012)
A Landscape of Driver Mutations in Melanoma
Eran Hodis et al.
CELL (2012)
Lymphatic Invasion Is Independently Prognostic of Metastasis in Primary Cutaneous Melanoma
Xiaowei Xu et al.
CLINICAL CANCER RESEARCH (2012)
Prevalence of BRAF V600E mutation in Chinese melanoma patients: Large scale analysis of BRAF and NRAS mutations in a 432-case cohort
Lu Si et al.
EUROPEAN JOURNAL OF CANCER (2012)
Publication of Tumor Marker Research Results: The Necessity for Complete and Transparent Reporting
Lisa M. McShane et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma
Farhad Azimi et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Prognostic Importance of the Mitotic Marker Phosphohistone H3 in Cutaneous Nodular Melanoma
Rita G. Ladstein et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
A Novel and Accurate Computer Model of Melanoma Prognosis for Patients Staged by Sentinel Lymph Node Biopsy: Comparison with the American Joint Committee on Cancer Model
Glenda G. Callender et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2012)
Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma
Sarah J. Storr et al.
MODERN PATHOLOGY (2012)
Melanoma molecular classes and prognosis in the postgenomic era
Elisa Tremante et al.
LANCET ONCOLOGY (2012)
The Prognostic Value of BRAF Mutation in Colorectal Cancer and Melanoma: A Systematic Review and Meta-Analysis
Gholamreza Safaee Ardekani et al.
PLOS ONE (2012)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
Douglas G. Altman et al.
PLOS MEDICINE (2012)
High Lymphatic Vessel Density and Lymphatic Invasion Underlie the Adverse Prognostic Effect of Radial Growth Phase Regression in Melanoma
Sook Jung Yun et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Clinical Relevance of Detection of Lymphovascular Invasion in Primary Melanoma Using Endothelial Markers D2-40 and CD34
Amy E. Rose et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma
Julie A. Ellerhorst et al.
CLINICAL CANCER RESEARCH (2011)
Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate
Suzanne Svobodova et al.
EUROPEAN JOURNAL OF CANCER (2011)
Identification of new genes associated with melanoma
Andreas Mauerer et al.
EXPERIMENTAL DERMATOLOGY (2011)
Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging Database
John F. Thompson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Prognosis in Patients With Sentinel Node-Positive Melanoma Is Accurately Defined by the Combined Rotterdam Tumor Load and Dewar Topography Criteria
Augustinus P. T. van der Ploeg et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma
Georgina V. Long et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma
Hongxiang Chen et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2011)
Prognostic value of galectin-3 in primary cutaneous melanoma
M. Buljan et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: An analysis of 215 cases from the Malmo Diet and Cancer Study
Liv Jonsson et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies
Sarah-Jane Schramm et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma
Bianca Devitt et al.
PIGMENT CELL & MELANOMA RESEARCH (2011)
Cytoplasmic Skp2 Expression Is Increased in Human Melanoma and Correlated with Patient Survival
Guangdi Chen et al.
PLOS ONE (2011)
Prognostic Significance of Sox4 Expression in Human Cutaneous Melanoma and Its Role in Cell Migration and Invasion
Seyed Mehdi Jafarnejad et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Predicting Survival Outcome of Localized Melanoma: An Electronic Prediction Tool Based on the AJCC Melanoma Database
Seng-jaw Soong et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma
Rita G. Ladstein et al.
BMC CANCER (2010)
Melanoma MicroRNA Signature Predicts Post-Recurrence Survival
Miguel F. Segura et al.
CLINICAL CANCER RESEARCH (2010)
Mutation-driven drug development in melanoma
Keith T. Flaherty et al.
CURRENT OPINION IN ONCOLOGY (2010)
EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria
Augustinus P. T. van der Ploeg et al.
EUROPEAN JOURNAL OF CANCER (2010)
Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline
Claus Garbe et al.
EUROPEAN JOURNAL OF CANCER (2010)
Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases
Charles M. Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
MicroRNA Expression Profiles Associated with Mutational Status and Survival in Malignant Melanoma
Stefano Caramuta et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins
Liqing Zhuang et al.
MODERN PATHOLOGY (2010)
Loss of SNF5 Expression Correlates with Poor Patient Survival in Melanoma
Hanyang Lin et al.
CLINICAL CANCER RESEARCH (2009)
Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival
Caroline Conway et al.
CLINICAL CANCER RESEARCH (2009)
A Multimarker Prognostic Assay for Primary Cutaneous Melanoma
Mohammed Kashani-Sabet et al.
CLINICAL CANCER RESEARCH (2009)
Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: Outcome analysis from a single-institution prospectively collected database
M. Mandala et al.
EUROPEAN JOURNAL OF CANCER (2009)
Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma
Liquing Zhuang et al.
HISTOPATHOLOGY (2009)
Melanoma Prognostic Model Using Tissue Microarrays and Genetic Algorithms
Bonnie E. Gould Rothberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Immunohistochemical detection of lymphovascular invasion with D2-40 in melanoma correlates with sentinel lymph node status, metastasis and survival
Fredrik Petersson et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2009)
The role of RhoC in growth and metastatic capacity of melanoma
Barbara Boone et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2009)
Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis
Katie Doeden et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2009)
Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysis
Bonnie E. Gould Rothberg et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival
Dusan Bogunovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Novel role for RGS1 in melanoma progression
Javier Rangel et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas
Ingeborg M. Bachmann et al.
BMC CANCER (2008)
Increased expression of the tumor suppressor PLZF is a continuous predictor of long-term survival in malignant melanoma patients
Georg Brunner et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2008)
Prognostic significance of cadherin-based adhesion molecules in cutaneous malignant melanoma
Gretchen M. Kreizenbeck et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Role of ING4 in human melanoma cell migration, invasion and patient survival
Jun Li et al.
CARCINOGENESIS (2008)
Predicting clinical outcome through molecular profiling in stage III melanoma
Thomas John et al.
CLINICAL CANCER RESEARCH (2008)
HER3 is a determinant for poor prognosis in melanoma
Markus Reschke et al.
CLINICAL CANCER RESEARCH (2008)
Lymphatic invasion revealed by multispectral imaging is common in primary melanomas and associates with prognosis
Xiaowei Xu et al.
HUMAN PATHOLOGY (2008)
Stratification of patients by melanoma cell adhesion molecule (MCAM) expression on the basis of risk: implications for sentinel lymph node biopsy
R. A. Pearl et al.
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2008)
Loss of BMI-1 expression is associated with clinical progress of malignant melanoma
Ingeborg M. Bachmann et al.
MODERN PATHOLOGY (2008)
High expression of DNA repair pathways is associated with metastasis in melanoma patients
A. Kauffmann et al.
ONCOGENE (2008)
Osteopontin as a molecular prognostic marker for melanoma
Javier Rangel et al.
CANCER (2008)
Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy
Katherine T. Morris et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Systematic search for the best gene expression markers for melanoma micrometastasis detection
J. Soikkeli et al.
JOURNAL OF PATHOLOGY (2007)
Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma
F. Piras et al.
HISTOPATHOLOGY (2007)
A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis
Soledad R. Alonso et al.
CANCER RESEARCH (2007)
Identification of high-risk patients among those diagnosed with thin cutaneous melanomas
Phyllis A. Gimotty et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma
Rebecca C. Taylor et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
NRAS and BRAF mutations in melanoma turnours in re ation to clinical characteristics:: a study based on mutation screening by pyrosequencing
Esther Edlundh-Rose et al.
MELANOMA RESEARCH (2006)
A gene expression signature associated with survival in metastatic melanoma
Susanna Mandruzzato et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2006)
Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes:: are these nodes to be considered negative?
A. C. J. van Akkooi et al.
ANNALS OF ONCOLOGY (2006)
Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma
Javier Rangel et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Tumor iNOS predicts poor survival for stage III melanoma patients
Suhendan Ekmekcioglu et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Gene expression profiling of primary cutaneous melanoma and clinical outcome
VR Winnepenninckx et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Metallothionein - overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients
G Weinlich et al.
BRITISH JOURNAL OF CANCER (2006)
CD44v3 levels in primary cutaneous melanoma are predictive of prognosis: Assessment by the use of tissue microarray
MD Pacifico et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma:: a case control study
D Massi et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Automated quantitative analysis of activator protein-2α subcellular expression in melanoma tissue microarrays correlates with survival prediction
AJ Berger et al.
CANCER RESEARCH (2005)
Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma
PA Gimotty et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Strong expression of IDI protein is associated with decreased survival, increased expression of ephrin-Al/EPHA2, and reduced thrombospondin-I in malignant melanoma
O Straume et al.
BRITISH JOURNAL OF CANCER (2005)
nm23 as a prognostic marker in primary cutaneous melanoma: evaluation using tissue microarray in a patient group with long-term follow-up
MD Pacifico et al.
MELANOMA RESEARCH (2005)
Identification of P-cadherin in primary melanoma using a tissue microarrayer - Prognostic implications in a patient cohort with long-term follow up
MD Pacifico et al.
ANNALS OF PLASTIC SURGERY (2005)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
BRITISH JOURNAL OF CANCER (2005)
Surveillance against tumors - is it mainly immunological?
G Klein et al.
IMMUNOLOGY LETTERS (2005)
Microtubule-associated protein 2, a marker of neuronal differentiation, induces mitotic defects, inhibits growth of melanoma cells, and predicts metastatic potential of cutaneous melanoma
MH Soltani et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
The gene expression signatures of melanoma progression
C Haqq et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma
S Scala et al.
CLINICAL CANCER RESEARCH (2005)
Development of a tissue array for primary melanoma with long-term follow-up: Discovering melanoma cell adhesion molecule as an important prognostic marker
MD Pacifico et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2005)
Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma
J Valencak et al.
EUROPEAN JOURNAL OF CANCER (2004)
Tenascin-C in primary malignant melanoma of the skin
S Ilmonen et al.
HISTOPATHOLOGY (2004)
Thin primary cutaneous malignant melanoma: A prognostic tree for 10-year metastasis is more accurate than American joint committee on cancer staging
PA Gimotty et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Automated quantitative analysis of HDM2 expression in malignant melanoma shows association with early-stage disease and improved outcome
AJ Berger et al.
CANCER RESEARCH (2004)
Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma
KA DiVito et al.
CANCER RESEARCH (2004)
High frequency of melanoma-associated antigen or HLA class I loss does not correlate with survival in primary melanoma
GFL Hofbauer et al.
JOURNAL OF IMMUNOTHERAPY (2004)
Progression in cutaneous malignant melanoma is associated with distinct expression profiles - A tissue microarray-based study
SR Alonso et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Skp2 and p27kip1 expression in melanocytic nevi and melanoma:: an inverse relationship
Q Li et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2004)
The development of optimal pathological assessment of sentinel lymph nodes for melanoma
MG Cook et al.
JOURNAL OF PATHOLOGY (2003)
Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma - An analysis of 3661 patients from a single center
MF Azzola et al.
CANCER (2003)
Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma
A Thies et al.
EUROPEAN JOURNAL OF CANCER (2002)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease
A Thies et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Differential expression of DNA nonhomologous end-joining proteins Ku70 and Ku80 in melanoma progression
M Korabiowska et al.
MODERN PATHOLOGY (2002)
High tPA-expression in primary melanoma of the limb correlates with good prognosis
CM Ferrier et al.
BRITISH JOURNAL OF CANCER (2000)
Molecular classification of cutaneous malignant melanoma by gene expression profiling
M Bittner et al.
NATURE (2000)
Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma
JM Karjalainen et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
